2012 Global Lyme Disease Diagnostics Market Outlook: Test Volumes, Sales Forecasts, and Supplier Shares by Country

Date: April 20, 2012
Pages: 203
Price:
US$ 3,080.00
License [?]:
Publisher: Venture Planning Group
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: G4616D0D11DEN
Leaflet:

Download PDF Leaflet

2012 Global Lyme Disease Diagnostics Market Outlook: Test Volumes, Sales Forecasts, and Supplier Shares by Country
The report presents a detailed analysis of the Lyme disease diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Lyme disease definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:
  • Hospitals
  • Commercial/Private Labs
    -Physician Offices
  • Public Health Labs
In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Lyme disease tests.

Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.

Contains 203 pages and 11 tables.
I. INTRODUCTION

II. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW


A. Background
  Clinical Description
  Clinical Case Definition
  Laboratory Criteria for Diagnosis
  Case Classification
B. Diagnostic Tests
C. Vaccines and Drugs
D. Emerging Diagnostic Technologies
  1. DNA Probes
    a. Technology Overview
    b. Amplification Methods
      Polymerase Chain Reaction
        Robotics
        Temperature Cyclers
        PCR Variations
      Immuno-PCR
      QC-PCR
      DAP-PCR
      Ligase Chain Reaction
      Branched DNA
      Q-Beta Replicase
      Nucleic-Acid Sequence-Based
      Strand Displacement Activation
      Self-Sustained Sequence Replicase
  2. Monoclonal Antibodies
  3. Immunoassays
    a. Technological Principle
    b. Enzyme Immunoassays (EIA)
      Overview
      ELISA
      Dot Immunobinding Assays
      Capillary Immunoassays
      Particle-Membrane Capture Immunoassays
      Enzyme Amplification
    c. Fluorescent Immunoassays
      Fluorescence Polarization
      Time-Resolved Pulse Fluorescence
    d. Luminescence
      Chemiluminescence
      Bioluminescence
    e. Latex Agglutination
    f. Immunoprecipitation
  4. Differential Light Scattering
  5. Microcomputers and Automation
  6. Artificial Intelligence
  7. Liposomes
  8. Flow Cytometry
  9. Chromatography
  10. MRI
  11. Gel Microdroplets
  12. Other

III. FRANCE: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

IV. GERMANY: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT

V. ITALY: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT

VI. JAPAN: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT

VII. SPAIN: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

VIII. UK: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT

IX. USA: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

X. ALTERNATIVE MARKET PENETRATION STRATEGIES


A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
  1. Marketing Approaches
  2. Product Complexity
  3. Customer Preference
  4. Established Suppliers
  5. Emerging Suppliers
  6. Major Types of Distributors
  7. Market Segmentation

XI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

XII. COMPETITIVE ASSESSMENTS

Abbott
Affymetrix
Applera
Beckman Coulter
Becton Dickinson
Binding Site
Biomerica
Biokit
bioMerieux
Bio-Rad
Biotrol
Biosite
Biotest
Caliper Technologies
Cepheid
Chemicon
Daiichi
DiaSorin
Diagast
Diamedix
Digene
Eiken
Enzo Biochem
Fujirebio
GenBio
Gene-Tec
Hemagen
Immunetics
Innogenetics
Inverness
J&J
Meridian
Nanogen
Nissui
Olympus
Provalis
Roche
Saliva Diagnostic
SeraCare
Siemens
Third Wave Technologies
Thermo Fisher
Tosho
Trinity Biotech
Tropix
Wampole Labs
Zenith
Zeus

LIST OF TABLES

Major Companies Developing or Marketing Lyme Disease Tests
France Lyme Disease Test Volume and Diagnostics Sales Forecast by Market Segment
France Lyme Disease Testing Market Diagnostics Sales by Major Supplier
Germany Lyme Disease Test Volume and Diagnostics Sales Forecast by Market Segment
Italy Lyme Disease Test Volume and Diagnostics Sales Forecast by Market Segment
Japan Lyme Disease Test Volume and Diagnostics Sales Forecast by Market Segment
Spain Lyme Disease Test Volume and Diagnostics Sales Forecast by Market Segment
Spain Lyme Disease Testing Market Diagnostics Sales by Major Supplier
U.K. Lyme Disease Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Lyme Disease Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Lyme Disease Testing Market Diagnostics Sales by Major Supplier

Ask Your Question

2012 Global Lyme Disease Diagnostics Market Outlook: Test Volumes, Sales Forecasts, and Supplier Shares by Country
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: